Drawing for Serial No. 87381427

USPTO serial 87381427

Serial No. 87381427

Reviewed by CopyMark Law Group

Reg. 5361427Status 710
Filing date
Status date
Registration date
Dec 19, 2017
Examiner
LEE, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 87381427?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David L. Sigalow

DAVID L. SIGALOW ALLEN, DYER, DOPPELT, MILBRATH & GILCHRIST, P.A.255 S. ORANGE AVENUE, SUITE 1401ORLANDO, FL 32801UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Rehabilitation and rehabilitation counseling of drug and alcohol addicted patientsSECTION 8 - CANCELLEDOct 27, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 5, 2024C8..CANCELLED SEC. 8 (6-YR)—
Dec 19, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 19, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 16, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 15, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 15, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 14, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 30, 2017IUAFUSE AMENDMENT FILED—
Oct 30, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 17, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 22, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 22, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 23, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 17, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 17, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 17, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 17, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 15, 2017DOCKASSIGNED TO EXAMINER—
Mar 28, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance